The pharmacist's role in HIV care in France

September 10, 2020

In France, antiretroviral treatment (ARV) can be dispensed by hospitals and/or community pharmacies. A recent study published in examined the pharmacist's role in HIV care in this country.

For the study, 2 national surveys were sent. The first was an anonymous questionnaire for people living with HIV, and the second was an online survey for community and hospital pharmacies. A total of 1,137 people living with HIV and 246 pharmacies responded.

The surveys pertained to medication interviews with pharmacists during ARV dispensing, where patients could receive explanations about efficacy and tolerance, recommendations for proper use of their medication, and advice about any drug interactions. The surveys also pertained to online patient medication files. When these files are offered by pharmacists and accepted by patients covered by health insurance, they can be used to record all the drugs dispensed during the previous four months. A patient's file thus constitutes a tool for coordinating prescriptions, generating advice, and identifying precautions in the use of different medications.

While the existence of the online medication file was known by 58% of people living with HIV, only 40% of pharmacists declared it to be systematically offered. It was offered to 17% of people living with HIV, and 80% of those people accepted it. Only 7% of people living with HIV felt well taken care of because they were offered medication interviews, but 32% said they would like to take advantage of this program. The results suggest the need for better implementation of medication files and interviews.
URL Upon Publication:


Related Antiretroviral Treatment Articles from Brightsurf:

Antiretroviral therapy can't completely stop accelerated cell aging seen in HIV
Untreated HIV infection is linked with epigenetic changes that suggest rapid aging.

Antiretroviral therapy fails to treat one-third of HIV patients in Malawi hospital
Antiretroviral therapy (ART) failure and drug resistance are extremely common in patients living with HIV who are admitted to hospital in Malawi, according to new research published in Lancet HIV.

Changes in the cost over tine of HIV antiretroviral therapy in US
Researchers calculated the average cost of recommended initial HIV antiretroviral therapy (ART) regimens in the US from 2012 to 2018 and analyzed how this cost has changed over the years.

Study suggests antiretroviral therapy does not restore disease immunity
A study led by researchers from SUNY Downstate Health Sciences University and Oregon Health & Science University, published in the Journal of Infectious Diseases, showed that, despite successful antiretroviral therapy (ART), antigen specific memory to vaccinations that occurred before HIV infection did not recover, even after immune reconstitution.

Researchers may have discovered where HIV takes refuge during antiretroviral treatment
An international team led by Professor Jerome Estaquier from Universite Laval's Faculty of Medicine may have discovered where in the body HIV takes refuge during antiretroviral treatment.

Immediate treatment with antiretroviral therapy helps infants with HIV
As part of an international collaborative effort, investigators from Brigham and Women's Hospital conducted immunological and virological testing on newborns in Botswana, finding that initiating antiretroviral therapy immediately, rather than waiting a few weeks, provided measurable benefits for infants born with HIV.

Early antiretroviral treatment shrinks the HIV reservoir in infected infants
Starting antiretroviral therapy within hours of birth drastically shrinks the reservoir of HIV virus -- an important step in efforts to cure infections -- and improves antiviral immune responses in newborns with HIV, shows a two-year study of a unique cohort of ten infants in Botswana.

HIV may affect the brain despite ongoing antiretroviral therapy
HIV-positive patients are living longer thanks to combination antiretroviral therapy (cART), but the virus can remain in some tissues, preventing a total cure.

Early antiretroviral treatment may preserve key immune responses to HIV
Investigators from the Ragon Institute of MGH, MIT and Harvard have found that instituting combination antiretroviral treatment at the earliest stages of HIV infection may allow the generation of functional CD8 'killer' T cells and preservation of the CD4 helper T cells that are the virus's primary target.

Being HIV positive and staying on antiretroviral therapy in Africa: A systematic review
An international team of researchers have carried out a review of the evidence examining what influences people who are HIV positive to go to health services and then stay on antiretroviral drugs in Africa.

Read More: Antiretroviral Treatment News and Antiretroviral Treatment Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to